{{Rsnum
|rsid=4274112
|Chromosome=1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=LIN28A
|position=26419708
|Gene_s=LIN28A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 11.5 | 39.8 | 48.7
| HCB | 5.1 | 23.5 | 71.3
| JPT | 2.7 | 27.4 | 69.9
| YRI | 7.5 | 48.3 | 44.2
| ASW | 8.8 | 43.9 | 47.4
| CHB | 5.1 | 23.5 | 71.3
| CHD | 0.9 | 17.4 | 81.7
| GIH | 24.8 | 41.6 | 33.7
| LWK | 7.3 | 34.5 | 58.2
| MEX | 14.0 | 59.6 | 26.3
| MKK | 5.8 | 45.8 | 48.4
| TSI | 5.9 | 51.5 | 42.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=25223935
|Title=Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}